ea0084ps2-07-66 | Graves’ Disease 1 | ETA2022
Matei Constantinescu Stefan
, Hospel Julien
, Daumerie Chantal
, Alexopoulou Orsalia
, Maiter Dominique
, Burlacu Maria-Cristina
Introduction: Thyrotropin receptor stimulating antibodies (TRAb) are responsible for GravesÂ’ disease (GD) manifestations. Other thyroid antibodies, namely thyroperoxidase (TPOAb) and thyroglobulin (TGAb) antibodies are highly prevalent in GD, but their roles in GD presentation and evolution are controversial.Methods: We retrospectively analysed TPOAb and TGAb levels and evolution in 88 consecutive patients with newly diagnosed GD between 2000 and 20...